¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø 2023 Kore-Japan Joint Symposium on Gene therapy in Inborn Errors of Immunity : 2023-02-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø 2023 Kore-Japan Joint Symposium on Gene therapy in Inborn Errors of Immunity : 2023-02-25
±³À°ÀÏÀÚ : 2023-02-25
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå  
±³À°ÁÖÁ¦ : 2023 Kore-Japan Joint Symposium on Gene therapy in Inborn Errors of Immunity 
ÁÖÃÖ±â°ü : »ï¼º¼­¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼Ò¾Æû¼Ò³â°ú  
´ã´çÀÚ : ¼ÛÁöÇý
¿¬¶ôó : 02-2148-7316  
À̸ÞÀÏ : smcpidoffice@naver.com      
±³À°Á¾·ù : ÀÇ»çÇР     
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 09:50~10:00 Opening Remark  Yae-Jean Kim(Samsung Medical Center, Sungkyunkwan University, Korea) 
±âŸ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 10:00~10:10 Introduction on gene therapy in Inborn Errors of Immunity  Yae-Jean Kim(Samsung Medical Center, Sungkyunkwan University, Korea) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 10:10~10:50 The first gene therapu in Japan: a long-term follow-up study of ADA (-) severe combined immunodeficiency paitens terated by retrovirs-stem cell gene therapy  Makoto Otsu(Kitasato University, Japan) 
È޽Ġ02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 10:50~11:00 Break  () 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 11:00~11:20 Genetic epidemiology of chronic granulomatous disease in Korea  Yae-Jean Kim(Samsung Medical Center, Sungkyunkwan University, Korea) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 11:20~12:00 Gene therapy for chronic granulomatous diseasa in Japan  Masafumi Onodera(National Center for child Health and Development, Japan) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 12:00~12:30 Retinal gene therapy : Current perspective  Sang Jin Kim(Samsung Medical Center, Sungkyunkwan University, Korea) 
½Ä»ç 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 12:30~13:30 Lunch time  () 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 13:30~14:00 Gene therapy in Duchenne musular dystrophy and spinal muscualr atrophy  Jee Hun Lee(Samsung Medical Center, Sungkyunkwan University, Korea) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 14:00~14:30 Overview of the lentiviral vector system for ex-vivo gene therapy  Yeon-Soo Kim(Chugnam National University, Korea) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 14:30~15:10 Experience of gene therapy clinical trial for Wiskoot-Aldrich syundrome in Japan  Toru Uchiyama(National Center for child Health and Development, Japan) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 15:10~15:30 Development of gene therapy for Inborn Errors of Immunity using targeted genome editing  Toru Uchiyama(National Center for child Health and Development, Japan) 
È޽Ġ02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 15:30~15:40 Break  () 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 15:40~16:10 Gene therapeutics based on ribozy-mediated RNA replacement/editing strategy  Seong-Wook Lee(Dankook University, RZnomics, Korea) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 16:10~16:50 Safety and efficacy evaluation for gene therapy produxts  Masafumi Onodera(National Center for child Health and Development, Japan) 
±âŸ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 16:50~17:50 Closing remark  Jee Hun Lee(Samsung Medical Center, Sungkyunkwan University, Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" »ï¼º¼­¿ïº´¿ø 2023 Kore-Japan Joint Symposium on Gene therapy in Inborn Errors of Immunity : 2023-02-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û â¿øÇѸ¶À½º´¿ø â¿ø½Ã â¿øÀÇ»çȸ ȸ¿ø¿¬¼ö±³À° : 2023-02-25
´ÙÀ½±Û 2023 ³úÁ¹Áß Àç°³Åë ½ÉÆ÷Áö¾ö ¹× ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ Ãá°èº¸¼ö±³À° : 2023-02-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21167 ±¤ÁÖ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦85ȸ ±¤ÁÖ °³¿øÀÇ ¹× Àü°øÀÇ ¿¬¼ö°­Á : 2024-07-19 0 27 2024-07-01
21166 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-07-19 0 22 2024-07-01
21165 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ·áÀÎ) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-07-19 0 26 2024-07-01
21164 ÀüºÏ ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦299Â÷ ¿ù·ÊÁý´ãȸ : 2024-07-19 0 25 2024-07-01
21163 ºÎ»ê ´ëÇÑÀçÈ°ÀÇÇÐȸ Á¦164Â÷ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2024-07-18 0 20 2024-07-01
21162 °æ±â ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-°æÀÎ(³²ºÎ) : 2024-07-16 0 20 2024-07-01
21161 ¼­¿ï 2024³â 1Â÷ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ °¡Á¤ÀÇÇб³½Ç ¿¬¼ö°­Á : 2024-07-14 0 24 2024-07-01
21160 ¼­¿ï 2024 Á¦16ȸ ´ëÇѼºÇü¿Ü°úÇÐȸ ´«¼ºÇü¿¬±¸È¸ Çмú½ÉÆ÷Áö¾ö : 2024-07-14 0 18 2024-07-01
21159 ¼­¿ï Á¦11ȸ ´ëÇѺñ°úÇÐȸ ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-14 0 22 2024-07-01
21158 ¼­¿ï °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ 2024³â ⸳62ÁÖ³â±â³ä ½ÉÆ÷Áö¾ö : 2024-07-13 0 18 2024-07-01
21157 ¼­¿ï Á¦46ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ ¿öÅ©¼¥ : 2024-07-13 0 18 2024-07-01
21156 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø 24³â ´ëµ¿¸Æ ½ÉÆ÷Áö¿ò : 2024-07-13 0 26 2024-07-01
21155 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Á¦18Â÷ ÁöµµÀü¹®ÀÇ ±³À° : 2024-07-13 0 6 2024-07-01
21154 ¼­¿ï 2024 ¿¬¼¼ÀÇ´ë Á¤Çü¿Ü°úÇб³½Ç ½ÉÆ÷Áö¿ò : ÃÖÁ¾Çõ ±³¼ö Á¤³â±â³ä : 2024-07-13 0 18 2024-07-01
21153 ¼­¿ï ´ëÇÑ¿Ü»óÁßȯÀÚ¿Ü°úÇÐȸ Á¦50Â÷ Áý´ãȸ (Management of upper & lower GI bleeding) : 2024-07-13 0 19 2024-07-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷